
Capitalize on the rapidly growing metabolic healthcare sector by investing in established pharmaceutical leaders like Novo Nordisk (NVO), which maintains dominant market share with its branded GLP-1 drug, Wegovy.
For high-growth potential, consider digital health platforms like Hims & Hers Health (HIMS) as they capture rising direct-to-consumer demand through affordable, subscription-based GLP-1 weight-loss treatments.
Within the residential real estate sector, shift focus toward multi-family housing and rental operators to benefit from severe home affordability constraints that are keeping younger demographics in the rental market longer.
On a personal finance level, incorporate legal asset protection tools such as prenuptial agreements and separated account structures to proactively manage wealth preservation amid shifting economic and generational dynamics.

By @theprofgpod
NYU Professor, best-selling author, business leader and serial entrepreneur Scott Galloway cuts through the biggest stories in ...